Sacks Michael S, Hamamoto Hirotsugu, Connolly Jeanne M, Gorman Robert C, Gorman Joseph H, Levy Robert J
Department of Bioengineering, Engineered Tissue Mechanics Laboratory, McGowan Institute for Regenerative Medicine, 100 Technology Drive, Room 234, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Biomaterials. 2007 Dec;28(35):5390-8. doi: 10.1016/j.biomaterials.2007.08.021. Epub 2007 Sep 5.
While glutaraldehyde crosslinking is most often used to fabricate bioprosthetic heart valves (BHV) using heterograft tissues, it predisposes BHV to calcification and dramatically stiffens the heterograft tissues. Our group previously reported the synthesis and characterization of a novel epoxy-crosslinker, triglycidylamine (TGA). TGA pretreatment of BHV tissues compared to glutaraldehyde results in both calcification resistance in subdermal implants and improved leaflet compliance. In these prior studies, optimal calcification inhibition was noted with the combined use of TGA with mercapto-aminobisphosphonate (MABP). In the present study, we investigated the hypothesis that bovine pericardium cross-linked with TGA-MABP retains these beneficial biomechanical properties in vivo using a novel mitral valve anterior leaflet (MVAL) ovine valvuloplasty model. Bovine pericardial specimens were crosslinked with either glutaraldehyde or TGA-MABP, from which 1cm2 sections were implanted in the ovine MVAL after removal of the original tissue of the same size. An array of four sonomicrometry transducers were implanted on the corners and used to compute the complete in-surface strain tensor cardiac cycle over the cardiac cycle at 0 and 4 weeks. Following explant samples were fixed in formalin for histology studies. At 4 weeks both treatment groups experienced no dimensional changes in the unloaded state, indicating no shrinkage. When fully loaded during peak systolic ejection, TGA-MABP valvuloplasty patches were significantly more compliant, which did not change at 4 weeks. In contrast, the glutaraldehyde areal strain increased significantly by 4 weeks. Estimated implant stresses for both treatment groups, based on previously measured biomechanical properties [Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, et al. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Am J Pathol 2005;166(1):1-13], were 40 and 250 kPa in the circumferential and radial directions, respectively, which are comparable to predicted BHV peak stress levels. We conclude that TGA-MABP crosslinked bovine pericardium, when subjected to in vivo BHV stress levels in a blood-contacting environment, maintains stable functionality.
虽然戊二醛交联最常用于使用异种移植组织制造生物人工心脏瓣膜(BHV),但它会使BHV易于钙化,并显著使异种移植组织变硬。我们的团队此前报道了一种新型环氧交联剂三缩水甘油胺(TGA)的合成与表征。与戊二醛相比,用TGA对BHV组织进行预处理可使皮下植入物具有抗钙化性能,并改善瓣叶顺应性。在这些先前的研究中,发现TGA与巯基氨基双膦酸盐(MABP)联合使用时,钙化抑制效果最佳。在本研究中,我们使用一种新型二尖瓣前叶(MVAL)羊瓣膜成形术模型,研究了用TGA-MABP交联的牛心包在体内是否保留这些有益的生物力学特性这一假设。将牛心包标本用戊二醛或TGA-MABP进行交联,去除相同大小的原始组织后,将1平方厘米的切片植入羊的MVAL中。在四个角上植入一组四个超声心动图换能器,用于计算在0周和4周时心动周期内整个表面应变张量的完整情况。取出后的样本用福尔马林固定用于组织学研究。在4周时,两个治疗组在无负荷状态下均未出现尺寸变化,表明没有收缩。在收缩期峰值射血时完全加载时,TGA-MABP瓣膜成形术贴片的顺应性明显更高,且在4周时没有变化。相比之下,戊二醛组的面积应变在4周时显著增加。根据先前测量的生物力学特性[康诺利JM,阿尔费里耶夫I,克拉克-格鲁埃尔JN,艾德尔曼N,萨克斯M,帕尔马托里E等。猪主动脉瓣叶或牛心包的三缩水甘油胺交联可改善生物相容性、生物力学和抗钙化性能:化学和生物学机制。《美国病理学杂志》2005;166(1):1 - 13],两个治疗组在圆周方向和径向方向的估计植入应力分别为40和250 kPa,这与预测的BHV峰值应力水平相当。我们得出结论,TGA-MABP交联的牛心包在血液接触环境中承受体内BHV应力水平时,能维持稳定的功能。